EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Value of the Run-In Period to Evaluate the Safety of Conventional Trypanocidal Treatment: A Subanalysis of a Colombian Randomized Clinical Trial

Juan Carlos Villar, Helena Arango, Luis David Sáenz-Pérez, Antonia Camacho

The American Journal of Tropical Medicine and Hygiene · 03.06.2026 · 114 (6) · 1148-1156

DOI: 10.4269/ajtmh.25-0198 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 03.06.2026. Verfasst von Juan Carlos Villar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia. Hauptthemen laut MEDLINE: Trypanocidal Agents, Nitroimidazoles, Nifurtimox, Chagas Disease. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When testing poorly tolerated or long-term treatments, including a run-in phase enhances clinical trial efficiency and internal validity by selecting more adherent participants. This report describes the adherence and tolerance of Colombian participants in EQUITY (a randomized, concealed, parallel-group, placebo-controlled trial testing nifurtimox and benznidazole among Trypanosoma cruzi –seropositive adults without cardiomyopathy). Our design included a 10-day, single-blind, placebo run-in phase. On completion, willing participants reporting good adherence (≥80%) and tolerance were randomized to any five 120-day, blinded treatments: four with either active medication, each given as 120-day half dose or 60-day full dose (followed/preceded by a randomly allocated 60-day placebo treatment), or a 120-day placebo. Side effects were compared after the run-in (day 0) between excluded and enrolled participants, and between those randomized to active medications or placebo 20 days after starting each treatment period (days 20/80). Those excluded (44/351, 12.5%) more often reported gastrointestinal (15.9/4.6%), nonspecific (13.7/4.2%), and musculoskeletal symptoms (9.1/1.6%) than those randomized. Participants given nifurtimox ( n = 84) or benznidazole ( n = 86) versus placebo ( n = 126) on day 20 reported more nonspecific (15.5/10.5/4.8%, respectively) or cutaneous side effects (6.0/12.8/3.2%). When starting active treatments (transition OFF–ON, n = 171 and n = 61 in first and second 60-day treatment periods), more participants reported emerging-worsening than receding-ending side effects (49/13 and 15/5, respectively). Despite inducing a nocebo effect, the run-in phase highlighted more closely related side effects, strengthening causal inference and informing adherence and tolerance to conventional trypanocides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanocidal AgentsNitroimidazolesNifurtimoxChagas DiseaseHumansColombiaFemaleMaleAdultTrypanosoma cruziSingle-Blind MethodMiddle Aged

Substanzen

Trypanocidal AgentsNitroimidazolesbenzonidazoleNifurtimox

Autor:innen und Institutionen

  • Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
  • Subdirección de Investigaciones, Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia.

Zitieren

APA

Villar, J. C., Arango, H., Sáenz-Pérez, L. D., & Camacho, A. (2026). Value of the Run-In Period to Evaluate the Safety of Conventional Trypanocidal Treatment: A Subanalysis of a Colombian Randomized Clinical Trial. The American Journal of Tropical Medicine and Hygiene, 114(6), 1148-1156. https://doi.org/10.4269/ajtmh.25-0198

Vancouver

Villar JC, Arango H, Sáenz-Pérez LD, Camacho A. Value of the Run-In Period to Evaluate the Safety of Conventional Trypanocidal Treatment: A Subanalysis of a Colombian Randomized Clinical Trial. The American Journal of Tropical Medicine and Hygiene. 2026;114(6):1148-1156. doi:10.4269/ajtmh.25-0198

BibTeX
@article{Villar2026,
  author = {Villar, Juan Carlos and Arango, Helena and Sáenz-Pérez, Luis David and Camacho, Antonia},
  title = {Value of the Run-In Period to Evaluate the Safety of Conventional Trypanocidal Treatment: A Subanalysis of a Colombian Randomized Clinical Trial},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2026},
  volume = {114},
  number = {6},
  pages = {1148--1156},
  doi = {10.4269/ajtmh.25-0198}
}
Kostenlos starten →